Concepedia

Chris Bryant

CB

Statistics

Publications

16

Citations

1.4K

H-Index

16

Active since

1997

Affiliations

Granta Design (United Kingdom)(Current)

University of North Carolina at Chapel Hill

University of Bath

Ninewells Hospital

Stony Brook University

Chris Bryant is an author at Granta Design (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1997–2024

16

Publications

16

Transgenic sickle mice have vascular inflammation

John D. Belcher, Chris Bryant, Julia Nguyen et al. · Blood · 2003 · 235 citations · Full text

Antibiotic collateral sensitivity is contingent on the repeatability of evolution

Daniel Nichol, Joseph Rutter, Chris Bryant et al. · Nature Communications · 2019 · 192 citations · Full text

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Chris Bryant, Rebecca Rawlinson, Andrew J. Massey · BMC Cancer · 2014 · 110 citations · Full text

Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site

Joanna C. Fowler, Charlotte King, Chris Bryant et al. · Cancer Discovery · 2020 · 98 citations · Full text

Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution

Andrew Potter, Victoria Oldfield, Claire L. Nunns et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 97 citations · Full text

, , +9

1–5 of 16